Skip to content

Herbalife Nutrition stock

HLFNYSE

Herbalife Nutrition Ltd., Consumer DefensiveISIN KYG4412G1010

$15.21▼ $0.34 (−2.2%)Closing price of 12 Nov 2026

69Score 69 out of 100, Neutral

Turn on early warning

Price and trend

69 / 100

Price history

+63% in one year

The chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Above the 200-day line: the price is 9.2% above it.

Trend change

Since July 2026 the 50-day line has been below the 200-day line; the trend has turned down.

Momentum

Normal: the price is neither overheated nor sold off (RSI 68).

Distance to the high

The price is 24% below its 52-week high. Largest decline in 20 years: 92% (February 2019 to February 2025).

Chart figures for advanced users
SMA 50$13.22
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$13.93
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)68
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$8.80
The lowest closing price of the last twelve months.
Resistance$19.96
The highest closing price of the last twelve months.
Market cap
$1.6B
Div. yield
no dividend
9.1
includes one-off items, adjusted 6.8
Fair value
$30.11

Snapshot

Computed from the data by fixed rules, no AI

  • Herbalife Nutrition Ltd. belongs to the Packaged Foods industry (United States) and, with a market value of $1.6B, is number 53 of 76 companies in its industry on MEQIRI.
  • In fiscal 2025 it reported revenue of $5.04B (up 0.9% year on year) and earnings of $228.3M (down 10.2%).
  • MEQIRI Score 69 out of 100 (Neutral): rank 77 of 296 in Consumer Defensive, median 62.
Show more
  • Our model puts fair value at $30.11, with the price 49% below it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Earnings turn into cashFree cash flow 247% of earnings over the last 12 months.Fundamentals 100
  • Share buybacksShare count down 22% since 2020.Capital allocation 90
  • High return on capitalReturn on invested capital 26.8% in fiscal 2025, Packaged Foods median 7.3%.Profitability 69

Weaknesses

  • Volatile share priceVolatility 59% a year over the last 12 months.Stability 34
  • Interest barely coveredOperating profit covers interest only 2.3 times.Stability 34
69/ 100
MEQIRI Score
Neutral

Its standout strengths are fundamentals and valuation, while stability and growth hold the score back.

Daily figure as of 13 Nov 2026

How the score is calculated

Score overview

Fundamentals are strong, with stable profits and strong cash generation.

Profit consistency100% of years
Cash conversion (free cash flow to earnings, 12 months)247%
ROIC (12 months)25.7%
Positive free cash flow100% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk low

How well MEQIRI warns

One of the 30% with the lowest crash risk among smaller stocks.

From 2016 to 2025, 14 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.

What drives the risk

  • high price swings

What lowers it

  • solid fundamentals
  • low growth grade (crashed less often in the backtest)

Valuation

Valuation signal

Possible value trap
Price
$15.21
Fair value
$30.11
Gap to fair value
−49%

In our model the price counts as cheap below $21.51 and expensive above $50.19 (uncertainty high, based on the price swings of the past year).

Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $25.25, at 7.8% it would be $37.41.

Possible value trap: looks cheap, but high risk, weak growth.

Valuation metrics

0.56
6.2
Fair value (model)
$30.11

From the cash-flow model alone; the profit includes one-off items, so there is no industry value.

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

20 years

In the twelve months to 30 Sep 2026, revenue rose 6.4% on the twelve months before. Revenue has grown solidly since 2006, at about 5% per year.

Margins

20 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2025: gross 76%, operating 9%, net 5%.

Debt & balance sheet

latest quarter
−4.59
2.3x
1.19
Cash & equivalents
$409.2M

Debt is elevated. Keep an eye on the interest burden and refinancing.

Earnings

Next earnings
17 Feb 2027in 96 days
Last reported
2 Nov 2026EPS reported $0.64 (expected $0.62)above expectations

Analyst estimates

Earnings estimates have barely changed since 15 Oct 2026.

Fiscal 20262 analysts
Earnings per share
$2.43−0.6%
Revenue
$5.3B+0.9%
Fiscal 20272 analysts
Earnings per share
$3.03−0.6%
Revenue
$5.41B+0.4%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook confirmed

Share price after the results: −10.9%

Full year net sales outlook: up 1.5% to 5.5% reported and up 1% to 5% in constant currency; currency has moved unfavorably since February.

Supporting passage from the call, verbatim
“On a reported basis, we expect net sales to increase 1.5% to 5.5% year-over-year, including an approximately 50 basis point currency tailwind. On a constant currency basis, we expect net sales to increase 1% to 5% year-over-year.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 6 May 2026 (fiscal Q1 2026), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

One insider bought on the open market in the last 6 months, $13,572 in total. One insider sold, $619,556 in total.

Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.

  • L'Helias SophiePurchase

    4 Jun 2026, Board

    Shares
    1,200
    Price
    $11.31
    Value
    $13,572
  • Hicks TroySale

    19 May 2026, Chief Operating Officer

    Shares
    10,000
    Price
    $12.32
    Value
    $123,245
  • Hicks TroySale

    18 May 2026, Chief Operating Officer

    Shares
    38,377
    Price
    $12.93
    Value
    $496,311

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at Herbalife Nutrition

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

296 rated companies in Consumer Defensive

Rank 77 of 296
77/ 296
This company
69
Sector median
62

Categories against the sector median

ProfitabilityMedian of 296 companies69 (median 54)15 above the median
GrowthMedian of 296 companies18 (median 50)32 below the median
FundamentalsMedian of 296 companies100 (median 79)21 above the median
ValuationMedian of 291 companies with a value99 (median 65)34 above the median
StabilityMedian of 296 companies34 (median 68)34 below the median
Capital allocationMedian of 296 companies90 (median 62)28 above the median
Technical analysisMedian of 296 companies69 (median 64)5 above the median
MomentumMedian of 296 companies87 (median 59)28 above the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Packaged Foods

The next larger and next smaller companies by market value

All 76 Packaged Foods stocks

ETFs that hold Herbalife Nutrition

Held by 10 ETFs on Xetra. Shown per index: the ETF with the largest weight.

Show 5 more

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 8 May 2026)
  • Valuation signal Fairly valued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy